DEFINITION of polyneuropathy

Polyneuropathy is a widespread, systemic condition characterized by the simultaneous damage, dysfunction, or degeneration of multiple peripheral nerves throughout the body, typically in a symmetrical and length-dependent (stocking-glove) pattern. It is distinguished from mononeuropathy (which isolates a single nerve) and plexopathy (which affects a regional network of nerves). The underlying pathological mechanisms usually involve either axonal degeneration (damage to the nerve fiber itself) or demyelination (damage to the protective myelin sheath), which disrupts electrical signaling. While it is always pathological, it can arise from diverse etiologies including metabolic insults, toxic exposures, inflammatory or autoimmune attacks, and genetic mutations. The clinically relevant subtypes most commonly encountered in coding include diabetic polyneuropathy (E11.42), alcoholic polyneuropathy (G62.1), and inflammatory polyneuropathy (G61.9). It is commonly confused with multiple mononeuropathy (mononeuritis multiplex), but the key difference is that mononeuritis multiplex involves asymmetric damage to multiple distinct nerves discontinuously, whereas polyneuropathy is typically diffuse and symmetric.


ETYMOLOGY of polyneuropathy

greek

ComponentOriginMeaning
poly-Greek polys (πολύς)many,” “much” — multiplying or pluralizing prefix
neuro-Greek neuron (νεῦρον)nerve,” “sinew,” “cord
-pathyGreek patheia (πάθεια)Noun-forming suffix — “disease,” “suffering or condition of

The word entered English in the 1890s as polyneuropathy (noun), borrowed from Late Greek medical taxonomy, deriving from Greek polys, neuron, and pathos — literally “disease of many nerves.” The root neuro- (“nerve”) connects polyneuropathy to the entire -neuro family: neuropathy (disease of a nerve), neuralgia (nerve pain), and neurotoxicity (poisonous to nerves). The prefix poly- is highly productive in medical terminology, appearing in terms like polyuria, polycythemia, and polymyalgia.


🔀 ALIASES / ALTERNATE TERMS

  • polyneuropathic (adjective form — e.g., “polyneuropathic pain,” “polyneuropathic changes”)
  • peripheral neuropathy (lay and clinical synonym; broadly used in internal medicine and endocrinology, though technically polyneuropathy is a subtype of peripheral neuropathy)
  • axonopathy (cellular/physiologic subtype — form of the condition characterized primarily by axonal degeneration)
  • demyelinating polyneuropathy (cellular/physiologic subtype — form characterized by destruction of the myelin sheath)
  • diabetic peripheral neuropathy (DPN) (define this alias briefly and note its ICD-10-CM code — most common systemic endocrine form; E11.42)
  • CIDP (systemic or syndromic form — Chronic Inflammatory Demyelinating Polyneuropathy; autoimmune-related)
  • toxic polyneuropathy (define by cause — due to toxic agents like heavy metals, alcohol, or chemotherapy drugs)
  • critical illness polyneuropathy (define by cause — diffuse weakness/nerve disorder from prolonged ICU stays and systemic inflammation)
  • sensorimotor polyneuropathy (functional subtype — condition affecting both sensory and motor distinct nerve fibers)
  • small fiber polyneuropathy (anatomic subtype — preferential degeneration of A-delta and unmyelinated C fibers; often presents with severe pain and preserved reflexes)

🔗 RELATED TERMS

  • mononeuropathy — the opposite or singular form of polyneuropathy; localized damage to a single peripheral nerve rather than multiple, diffuse nerves.
  • radiculopathy — closely related clinical entity; damage occurring at the nerve root near the spinal cord rather than in the distal peripheral tracks.
  • mononeuritis multiplex — multiple asymmetric isolated nerve injuries; distinguished from polyneuropathy’s symmetric presentation; G60.8.
  • Charcot-Marie-Tooth disease — complex genetic syndrome that overlaps with this term; a hereditary motor and sensory polyneuropathy.
  • demyelination — the physiological mechanism of myelin loss; delays or blocks action potentials causing neuropathic symptoms.
  • neurotoxic — adjective describing chemical or pharmaceutical inputs that damage nerve tissue; e.g., “neurotoxic chemotherapy.”
  • Wallerian degeneration — cellular programmed process of nerve degeneration distal to a site of injury.
  • Guillain-Barré syndrome — acquired, acute inflammatory demyelinating disease synonymous with rapid-onset polyneuropathy; (G61.0).
  • amyloid polyneuropathy — clinical entity defined by peripheral nerve damage secondary to amyloid protein deposition; (E85.1).
  • EMG / NCS — primary electromyography and nerve conduction studies diagnostic tools for evaluating nerve amplitudes, latencies, and conduction velocities to classify polyneuropathies.

CODING CORNER

🏥 ICD-10-CM CODES

Inflammatory Polyneuropathies

CodeDescription
G61.0Guillain-Barre syndrome
G61.1Serum neuropathy
G61.81Chronic inflammatory demyelinating polyneuritis
G61.82Multifocal motor neuropathy
G61.89Other inflammatory polyneuropathies
G61.9Inflammatory polyneuropathy, unspecified

Other and Unspecified Polyneuropathies (Toxic, Critical Illness, etc.)

CodeDescription
G62.0Drug-induced polyneuropathy
G62.1Alcoholic polyneuropathy
G62.2Polyneuropathy due to other toxic agents
G62.81Critical illness polyneuropathy
G62.82Radiation-induced polyneuropathy
G62.89Other specified polyneuropathies
G62.9Polyneuropathy, unspecified

Polyneuropathy in Diseases Classified Elsewhere (Etiology/Manifestation)

CodeDescription
E10.42Type 1 diabetes mellitus with diabetic polyneuropathy
E11.42Type 2 diabetes mellitus with diabetic polyneuropathy
G63Polyneuropathy in diseases classified elsewhere

Hereditary and Idiopathic Neuropathy

CodeDescription
G60.0Hereditary motor and sensory neuropathy
G60.1Refsum’s disease
G60.2Neuropathy in association with hereditary ataxia
G60.3Idiopathic progressive neuropathy
G60.8Other hereditary and idiopathic neuropathies
G60.9Hereditary and idiopathic neuropathy, unspecified

🔧 COMMON CPT CODES (Polyneuropathy Diagnostic Testing)

CPT CodeDescription
95907Nerve conduction studies; 1-2 studies
95908Nerve conduction studies; 3-4 studies
95909Nerve conduction studies; 5-6 studies
95910Nerve conduction studies; 7-8 studies
95911Nerve conduction studies; 9-10 studies
95912Nerve conduction studies; 11-12 studies
95913Nerve conduction studies; 13 or more studies
95860Needle electromyography; one extremity with or without related paraspinal areas
95861Needle electromyography; two extremities with or without related paraspinal areas
95863Needle electromyography; three extremities with or without related paraspinal areas
95864Needle electromyography; four extremities with or without related paraspinal areas

⚠️ Coding Note: For inpatient profee and hospital claims, adherence to etiology/manifestation sequencing logic is critical for polyneuropathies. When coding conditions like diabetic polyneuropathy (E11.42) or polyneuropathy due to neoplastic disease (code first the neoplasm, followed by G63), the underlying cause must dictate the primary code sequence. An undercoding alert occurs frequently with G62.9 (Polyneuropathy, unspecified): providers frequently document “generalized weakness, bilateral foot numbness, and sensory loss” linked specifically to alcohol dependence or chemotherapy, but fail to explicitly state “alcoholic polyneuropathy” or “drug-induced polyneuropathy.” This should trigger a query to link the neuropathy back to the toxic agent (upgrading to G62.1 or G62.0). Furthermore, specific CPT codes for Nerve Conduction Studies (e.g., 95907-95913) require clear documentation of the exact number of distinct nerve studies and must be supported by medical necessity showing a systemic pattern rather than a localized focal neuropathy.



Med roots dictionary Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms